226 related articles for article (PubMed ID: 35119840)
1. Molecular Features of CA-074 pH-Dependent Inhibition of Cathepsin B.
Yoon MC; Christy MP; Phan VV; Gerwick WH; Hook G; O'Donoghue AJ; Hook V
Biochemistry; 2022 Feb; 61(4):228-238. PubMed ID: 35119840
[TBL] [Abstract][Full Text] [Related]
2. Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.
Yoon MC; Solania A; Jiang Z; Christy MP; Podvin S; Mosier C; Lietz CB; Ito G; Gerwick WH; Wolan DW; Hook G; O'Donoghue AJ; Hook V
ACS Chem Biol; 2021 Sep; 16(9):1628-1643. PubMed ID: 34416110
[TBL] [Abstract][Full Text] [Related]
3. Distinct Cleavage Properties of Cathepsin B Compared to Cysteine Cathepsins Enable the Design and Validation of a Specific Substrate for Cathepsin B over a Broad pH Range.
Yoon MC; Phan V; Podvin S; Mosier C; O'Donoghue AJ; Hook V
Biochemistry; 2023 Aug; 62(15):2289-2300. PubMed ID: 37459182
[TBL] [Abstract][Full Text] [Related]
4. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.
Montaser M; Lalmanach G; Mach L
Biol Chem; 2002; 383(7-8):1305-8. PubMed ID: 12437121
[TBL] [Abstract][Full Text] [Related]
5. Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L.
Bocock JP; Edgell CJ; Marr HS; Erickson AH
Eur J Biochem; 2003 Oct; 270(19):4008-15. PubMed ID: 14511383
[TBL] [Abstract][Full Text] [Related]
6. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
Lynas JF; Hawthorne SJ; Walker B
Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
[TBL] [Abstract][Full Text] [Related]
7. The slow-binding inhibition of cathepsin K by its propeptide.
Billington CJ; Mason P; Magny MC; Mort JS
Biochem Biophys Res Commun; 2000 Oct; 276(3):924-9. PubMed ID: 11027570
[TBL] [Abstract][Full Text] [Related]
8. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
Mason RW; Sol-Church K; Abrahamson M
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B-like activity predominates over cathepsin L-like activity in adult Schistosoma mansoni and S. japonicum.
Caffrey CR; Ruppel A
Parasitol Res; 1997; 83(6):632-5. PubMed ID: 9211519
[TBL] [Abstract][Full Text] [Related]
10. pH Dependence of inhibitors targeting the occluding loop of cathepsin B.
Cathers BE; Barrett C; Palmer JT; Rydzewski RM
Bioorg Chem; 2002 Aug; 30(4):264-75. PubMed ID: 12392705
[TBL] [Abstract][Full Text] [Related]
11. Epoxysuccinyl dipeptides as selective inhibitors of cathepsin B.
Gour-Salin BJ; Lachance P; Plouffe C; Storer AC; Ménard R
J Med Chem; 1993 Mar; 36(6):720-5. PubMed ID: 8459399
[TBL] [Abstract][Full Text] [Related]
12. Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.
Klose A; Zigrino P; Dennhöfer R; Mauch C; Hunzelmann N
Anal Biochem; 2006 Jun; 353(1):57-62. PubMed ID: 16620747
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development.
Rosenthal PJ; McKerrow JH; Rasnick D; Leech JH
Mol Biochem Parasitol; 1989 Jun; 35(2):177-83. PubMed ID: 2671722
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases.
Serveau C; Lalmanach G; Hirata I; Scharfstein J; Juliano MA; Gauthier F
Eur J Biochem; 1999 Jan; 259(1-2):275-80. PubMed ID: 9914503
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.
Bogyo M; Verhelst S; Bellingard-Dubouchaud V; Toba S; Greenbaum D
Chem Biol; 2000 Jan; 7(1):27-38. PubMed ID: 10662686
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteinases on lysosomal proteolysis in rat liver in vivo and in vitro.
Ohshita T; Nikawa T; Towatari T; Katunuma N
Eur J Biochem; 1992 Oct; 209(1):223-31. PubMed ID: 1382984
[TBL] [Abstract][Full Text] [Related]
17. Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo.
Towatari T; Nikawa T; Murata M; Yokoo C; Tamai M; Hanada K; Katunuma N
FEBS Lett; 1991 Mar; 280(2):311-5. PubMed ID: 2013329
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells.
Yoshii H; Kamiyama H; Minematsu K; Goto K; Mizota T; Oishi K; Katunuma N; Yamamoto N; Kubo Y
Virology; 2009 Nov; 394(2):227-34. PubMed ID: 19781728
[TBL] [Abstract][Full Text] [Related]
19. The binding mode of an E-64 analog to the active site of cathepsin B.
Feng MH; Chan SL; Xiang Y; Huber CP; Lim C
Protein Eng; 1996 Nov; 9(11):977-86. PubMed ID: 8961350
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: a possible mechanism of high dose tolerance.
Michallet MC; Saltel F; Flacher M; Revillard JP; Genestier L
J Immunol; 2004 May; 172(9):5405-14. PubMed ID: 15100281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
